UCM-13207 is a selective isoprenylcysteine carboxylmethyltransferase ( ICMT ) inhibitor with a human IC 50 of 1.4 μM and human K a of 7.2 μM. UCM-13207 modulates progerin localization, stability, and levels, reduces DNA damage, increases cellular viability, and decreases tissue senescence. UCM-13207 can be used for the research of Hutchinson−Gilford progeria syndrome.
Products | Products > Disease Areas > Others | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Others | Products > Signaling Pathways > ICMT
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.